Sep 28, 2026 07:01AM
Aug 31, 2026 08:32AM
Aug 6, 2026 07:50AM
May 7, 2026 07:45AM
May 4, 2026 04:06PM
Mar 12, 2026 12:26PM
Mar 5, 2026 11:33AM Lexicon Pharmaceuticals (LXRX) PT Raised to $6 at H.C. Wainwright
Mar 5, 2026 07:06AM
Jan 20, 2026 07:00AM
Dec 10, 2025 08:31AM
Nov 10, 2025 02:33AM
Nov 6, 2025 07:59AM
Oct 14, 2025 08:01AM
Sep 22, 2025 04:00PM Lexicon submits additional data to FDA for Zynquista diabetes drug review
Sep 11, 2025 06:50AM
Sep 9, 2025 06:50AM
Sep 8, 2025 08:31AM
Sep 3, 2025 06:50AM
Sep 2, 2025 08:33AM
Aug 7, 2025 08:09AM
Aug 6, 2025 12:06PM Lexicon Pharmaceuticals (LXRX) PT Raised to $0.85 at Jefferies
Aug 6, 2025 07:32AM
Jun 24, 2025 06:52AM
May 13, 2025 04:01PM
Apr 2, 2025 08:01AM
Mar 31, 2025 06:46AM
Mar 28, 2025 07:30AM
Mar 6, 2025 04:01PM Lexicon Pharma (LXRX) Tops Q4 EPS by 3c
Mar 4, 2025 06:46AM
Mar 3, 2025 07:01AM
Jan 3, 2025 08:23AM
Jan 2, 2025 08:04AM
Dec 12, 2024 06:47AM
Nov 25, 2024 06:39AM
Nov 22, 2024 07:33AM Lexicon Pharma (LXRX) to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA
Nov 20, 2024 04:06PM
Nov 12, 2024 04:10PM
Nov 12, 2024 04:05PM
Nov 1, 2024 07:22AM
Nov 1, 2024 06:40AM
Oct 31, 2024 07:01AM
Oct 23, 2024 09:05AM Lexicon Pharma (LXRX): New Analysis of Phase 3 Data Demonstrating Renal Protective Benefits of Sotagliflozin to be Presented at ASN
Oct 18, 2024 05:48AM
Oct 17, 2024 07:53AM
Oct 17, 2024 06:55AM
Oct 16, 2024 04:35PM
Oct 10, 2024 07:40AM
Oct 3, 2024 06:57AM
Sep 30, 2024 07:26AM H.C. Wainwright Reiterates Buy Rating on Lexicon Pharmaceuticals (LXRX)
Sep 16, 2024 06:57AM

479,183 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All